MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-DD-01-0000061
Bruck Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹58.81 Cr
▲ 3% YoY
Net profit · FY 2024
₹3.18 Cr
Net margin 5.4%
EBITDA · FY 2024
₹9.11 Cr
EBITDA margin 15.5%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.68 Cr
Issued & subscribed
Open charges
₹21.03 Cr
Satisfied ₹7.1 Cr
Company age
42 yrs
Est. 1984
Employees · EPFO
123
Provident fund records
About Bruck Pharma Private Limited
Data last updated:
Bruck Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 August 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1984PTC416799. Its GSTIN is 27AABCB0548E2Z2 (Maharashtra). The company holds 6 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.68 Cr. It was formerly known as Brucke Pharma Pvt Ltd. It is led by directors Shirish Devendra Kejriwal and Anshu Devendra Kejriwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹58.81 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹3.18 Cr (net margin 5.4%) and EBITDA of ₹9.11 Cr (EBITDA margin 15.5%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 38% over five years.
The company has about 123 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹21.03 Cr and satisfied charges of ₹7.1 Cr on record. Court records list 23 cases involving the company, including 8 filed by the company and 15 filed against it; 2 cases are pending. The company has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹16.41 Cr; the latest was in March 2022. The company has 4 MSME Form 1 returns on record between 2022 and 2023, listing 47 overdue payments to 5 micro and small suppliers.
Bruck Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DD-01-0000061). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bruck.in.
Company details
CIN U24239MH1984PTC416799
Registration Number 416799
Incorporation Date 23 August 1984
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DD-01-0000061
Name history
Bruck Pharma has undergone 2 name changes throughout its history. The company was previously known as Brucke Pharma Pvt Ltd, and Bruck Pharma Private Limited. The current legal name is Bruck Pharma Private Limited.
| Company Name | Status |
|---|---|
| Bruck Pharma Private Limited | Current |
| Brucke Pharma Pvt Ltd | Previous |
CIN history
Bruck Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239MH1984PTC416799, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH1984PTC416799 | Current |
| U24239MH1984PLC416799 | Previous |
| U24239WB1984PTC037865 | Previous |
Recognitions & Rankings of Bruck Pharma
Contact details
Bruck Pharma Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressOffice No.405 4th Floor B Wing Cello Triumph, I B Patel Road, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Bruck Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bruck Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bruck Pharma Private Limited, buy the company report.
Financials of Bruck Pharma Private Limited
FY 2025 filings availableBruck Pharma Private Limited reported revenue of ₹58.81 Cr (up 3% YoY) for FY 2024.
Revenue · FY 2024
₹58.81 Cr ▲ 3%
Net profit · FY 2024
₹3.18 Cr margin 5.4%
EBITDA · FY 2024
₹9.11 Cr margin 15.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 24%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 1%
5 years · compounded
▲ 58%
Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 3% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹58.81 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.18 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.5% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bruck Pharma Private Limited, buy the company report.
Board of directors of Bruck Pharma Private Limited
Bruck Pharma has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shirish Devendra Kejriwal Also directs: Brucke Biocare Private Limited | Director | 25 May 2009 | 17 Years 5 Months | Current |
| Anshu Devendra Kejriwal Also directs: Brucke Biocare Private Limited | Director | 02 Jul 2010 | 16 Years 3 Months | Current |
Charges & borrowings
Open charges
₹21.03 Cr
Satisfied charges
₹7.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Aug 2024 | 100984984 | Others | ₹1.5 Cr | Open | |
| 24 Feb 2023 | 100687357 | Others | ₹4.89 Cr | Open | |
| 24 Feb 2023 | 100688171 | Others | ₹3.09 Cr | Open | |
| 28 Jan 2022 | 100527639 | Others | ₹1.81 Cr | Open | |
| 07 Jan 2022 | 100521109 | Others | ₹24 Lakh | Open |
To see the full charge records of Bruck Pharma Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Bruck Pharma Private Limited has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹16.41 Cr; the latest was in March 2022.
Total deals
10
Secondary share transfers
7
Funding rounds
3
Disclosed funding
₹16.41 Cr
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Funding round | ₹10.33 Cr | Investors: Legendry Nirman Private Limited , Kamdar Agriculture Private Limited |
| Feb 2022 | Secondary share transfer | Undisclosed | Buyer: Legendry Nirman Private Limited Seller: 3 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Kamdar Agriculture Private Limited , Nutech Commosales Private Limited |
| Jan 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Bhuvneshewari Vyapaar Private Limited |
| Mar 2013 | Funding round | ₹45 Lakh | Investors: Bhuvneshewari Vyapaar Private Limited |
To see the full deal history of Bruck Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bruck Pharma Private Limited has 23 court cases on record: 8 filed by Bruck Pharma, 15 filed against it. 2 cases are pending and 21 are disposed.
Total cases
23
Filed by the company
8
Filed against the company
15
Pending
2
Disposed
21
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 11 | 5 | 0 |
| District courts | 10 | 8 | 2 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (Cri.Rev.App.) | Filed against the company by Fabtech Technologies International Limited and 2 Ors (65Th M M Court Andheri Mumbai) and 2 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrent Cases SW) | Filed against the company by an individual | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| NCLAT, NCLAT New Delhi | Company appeal | Filed by the company against individuals | Disposed |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against individuals | Disposed |
To see the full case history of Bruck Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Bruck Pharma Private Limited was last rated by Crisil on 08 May 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 08 May 2020 |
To see the full credit ratings and regulatory alerts of Bruck Pharma Private Limited, buy the company report.
MSME payment delays
Bruck Pharma Private Limited has 4 MSME Form 1 returns on record between 2022 and 2023, listing 47 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Swastik Print & Pack | |||
| Jhunjhunwala Jain & Associates LLP | |||
| Shubham Prints LLP |
To see the full MSME payment records of Bruck Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Bruck Pharma has 6 GST registrations: 3 active and 3 cancelled or inactive.
Total GSTINs
6
Active
3
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB0548E2Z2 | Maharashtra | Active | 23 Feb 2022 |
| 24AABCB0548E1Z9 | Gujarat | Active | 01 Jul 2017 |
| 26AABCB0548E1Z5 | Daman & Diu | Active | 01 Aug 2020 |
To see the full GST registrations and return filing status of Bruck Pharma Private Limited, buy the company report.
Recent activity
Bruck Pharma Private Limited has 13 board changes on record since 2009: 2 appointments and 11 cessations. The latest: Meenadevi Bishnodev Kejriwal ceased to be Additional Director on 05 Dec 2024.
Charges
A charge with Others of Rs. 1.81 Cr registered on 28 Jan 2022 with Charge ID 100527639 was modified on 05 Dec 2025.
AGM
Bruck Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bruck Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Meenadevi Bishnodev Kejriwal ceased to be Additional Director.
Ceased
Ashokkumar Bhagirath Tiwari ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100984984 was registered on 26 Aug 2024.
Charges
A charge with Others of Rs. 9.50 Cr registered on 20 Jun 2016 with Charge ID 100036183 was modified on 26 Aug 2024.
Charges
A charge with Others amounted to Rs. 4.89 Cr with Charge ID 100687357 was registered on 24 Feb 2023.
Charges
A charge with Others amounted to Rs. 3.09 Cr with Charge ID 100688171 was registered on 24 Feb 2023.
Charges
A charge with Others amounted to Rs. 1.81 Cr with Charge ID 100527639 was registered on 28 Jan 2022.
Charges
A charge with Others amounted to Rs. 0.24 Cr with Charge ID 100521109 was registered on 07 Jan 2022.
Charges
A charge registered on 11 Oct 2017 via Charge ID 100132885 with Others was fully satisfied on 03 Aug 2021.
16 earlier events are in the company report.
Frequently asked questions
Bruck Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 August 1984 (42+ years old) and is registered under CIN U24239MH1984PTC416799.
Bruck Pharma has 2 current directors:
- Shirish Devendra Kejriwal - Director
- Anshu Devendra Kejriwal - Director
The latest financial statements of Bruck Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bruck Pharma is 27AABCB0548E2Z2, registered in Maharashtra. The company has 6 GST registrations in all, of which 3 are active and 3 are cancelled or inactive. Other active GSTINs include 24AABCB0548E1Z9 (Gujarat), 26AABCB0548E1Z5 (Daman & Diu).
The CIN (Corporate Identification Number) of Bruck Pharma is U24239MH1984PTC416799. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bruck Pharma has 23 court cases on record: 8 filed by the company and 15 filed against it. 2 are pending. Most are in the nclat.
Bruck Pharma was incorporated on 23 August 1984, making it 42+ years old. It is registered with the Registrar of Companies, Mumbai.
Bruck Pharma has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹16.41 Cr; the latest was in March 2022.
Meenadevi Bishnodev Kejriwal ceased to be Additional Director on 05 Dec 2024. Ashokkumar Bhagirath Tiwari ceased to be Additional Director on 28 Aug 2024. Devendra Kumar Kejriwal ceased to be Director on 20 Jul 2021. Bruck Pharma has 13 board changes on record in total.
Yes, Bruck Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-DD-01-0000061).
Bruck Pharma has 4 MSME Form 1 returns on record between 2022 and 2023, listing 47 overdue payments to 5 micro and small suppliers. The latest return was filed on 29 Aug 2023.